Moderna Won’t Enforce Covid Vaccine Patents During Pandemic (1)

Oct. 8, 2020, 3:28 PM UTC

Moderna Inc. said it wouldn’t enforce its patents related to Covid-19 vaccines during the pandemic, in an effort to not deter other companies and researchers from making similar shots.

“While the pandemic continues, Moderna will not enforce our Covid-19 related patents against those making vaccines intended to combat the pandemic,” the company said in a statement on Thursday.

One of the front-runners in developing a Covid-19 vaccine, Moderna decided to make the declaration because investors had started noticing that the company has patents that might apply to other coronavirus vaccines, said Stephen Hoge, Moderna’s president, in an interview.

The ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.